Effect of halothane on ischemic brain edema. 1990

R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
Department of Experimental Therapy, SIR International, France.

Halothane anesthesia (2%) given continuously during the ischemic and post-ischemic period in gerbils does not protect against cytotoxic edema but counteracts superimposed vasogenic edema due to the first BBB opening to serum protein during the reflow period, thus allowing specific gravity values at 1-hour reflow to return to initial levels. It seems likely that this effect of halothane is due to a reduction of the hyperemia by halothane, which reduces both blood pressure and brain metabolism. CBF measurements in halothane-treated animals also indicated that intense early postischemic hypoperfusion may well exist in the absence of brain edema.

UI MeSH Term Description Entries
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005849 Gerbillinae A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. Gerbils,Jird,Meriones,Psammomys,Rats, Sand,Gerbil,Jirds,Merione,Rat, Sand,Sand Rat,Sand Rats
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015424 Reperfusion Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY. Reperfusions

Related Publications

R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
June 1988, Neurologia medico-chirurgica,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
September 1987, Neurologia medico-chirurgica,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
January 1997, Acta neurochirurgica. Supplement,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
August 2002, Zhonghua yi xue za zhi,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
January 1999, Progress in cardiovascular diseases,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
January 1994, Acta neurochirurgica. Supplementum,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
February 1978, Polski przeglad chirurgiczny,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
January 1978, European neurology,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
June 1987, No to shinkei = Brain and nerve,
R Cahn, and J M Dupont, and M G Borzeix, and J Cahn
July 1990, Neurosurgery,
Copied contents to your clipboard!